Glycaemic status in relation to oxidative stress and inflammation in well-controlled type 2 diabetes subjects

British Journal of Nutrition

Volumn 101, Issue 10, 2009, Pages 1423-1426

  Rytter, Elisabet ^a   Vessby, Bengt ^a   Åsgård, Rikard ^b   Johansson, Clara ^b   Sjödin, Anders ^c   Abramsson Zetterberg, Lilianne ^d   Möller, Lennart ^b   Basu, Samar ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d NATIONAL FOOD ADMINISTRATION   (Sweden)

Author keywords

Diabetes mellitus type 2; Glycaemic control; Inflammation; Oxidative stress

Indexed keywords

13,14 DIHYDRO 15 OXOPROSTAGLANDIN F2 ALPHA; 3 NITROTYROSINE; 8 HYDROXYDEOXYGUANOSINE; 8 ISOPROSTAGLANDIN F2 ALPHA; ANTIDIABETIC AGENT; C REACTIVE PROTEIN; DNA FORMAMIDOPYRIMIDINE GLYCOSYLASE; HEMOGLOBIN A1C; INSULIN; INTERLEUKIN 6; MALONALDEHYDE; PROSTAGLANDIN F2 ALPHA;

ADULT; AGED; ARTICLE; BODY MASS; CORRELATION ANALYSIS; DIET THERAPY; ENZYME BLOOD LEVEL; ERYTHROCYTE; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; INFLAMMATION; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; URINALYSIS; WAIST CIRCUMFERENCE; WEIGHT;

AGED; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BODY MASS INDEX; C-REACTIVE PROTEIN; DEOXYGUANOSINE; DIABETES MELLITUS, TYPE 2; DINOPROST; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INFLAMMATION; INSULIN; INTERLEUKIN-6; LIPIDS; MALE; MALONDIALDEHYDE; MIDDLE AGED; OBESITY; OXIDATIVE STRESS; PROBABILITY; STATISTICS, NONPARAMETRIC; TYROSINE; WAIST CIRCUMFERENCE;

EID: 67649432534     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114508076204     Document Type: Article

References (24)

1. Jialal I, Devaraj S & Venugopal SK (2002) Oxidative stress, inflammation, and diabetic vasculopathies: The role of alpha tocopherol therapy. Free Radic Res 36, 1331-1336.
2. Pickup JC (2004) Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care 27, 813-823.
3. Ceriello A (2000) Oxidative stress and glycaemic regulation. Metabolism 49, 27-29.
4. Bonnefont-Rousselot D (2002) Glucose and reactive oxygen species. Curr Opin Clin Nutr Metab Care 5, 561-568.
5. Helmersson J, Vessby B, Larsson A, et al. (2004) Association of type 2 diabetes with cyclooxygenase-mediated inflammation and oxidative stress in an elderly population. Circulation 109, 1729-1734.
6. Pickup JC, Mattock MB, Chusney GD, et al. (1997) NIDDM as a disease of the innate immune system: Association of acute-phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia 40, 1286-1292.
7. Duncan BB, Schmidt MI, Pankow JS, et al. (2003) Low-grade systemic inflammation and the development of type 2 diabetes: The atherosclerosis risk in communities study. Diabetes 52, 1799-1805.
8. Friedewald WT, Levy RI & Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18, 499-502.
9. Gedik CM & Collins A (2005) Establishing the background level of base oxidation in human lymphocyte DNA: Results of an interlaboratory validation study. FASEB J 19, 82-84.
10. Hofer T & Moller L (2002) Optimization of the workup procedure for the analysis of 8-oxo-7,8-dihydro-2′-deoxyguanosine with electrochemical detection. Chem Res Toxicol 15, 426-432.
11. Nagy E, Johansson C, Zeisig M, et al. (2005) Oxidative stress and DNA damage caused by the urban air pollutant 3-NBA and its isomer 2-NBA in human lung cells analyzed with three independent methods. J Chromatogr B Anal Technol Biomed Life Sci 827, 94-103.
12. Abramsson-Zetterberg L, Durling LJ, Yang-Wallentin F, et al. (2006) The impact of folate status and folic acid supplementation on the micronucleus frequency in human erythrocytes. Mutat Res 603, 33-40.
13. Ohrvall M, Tengblad S, Ekstrand B, et al. (1994) Malondialdehyde concentration in plasma is inversely correlated to the proportion of linoleic acid in serum lipoprotein lipids. Atherosclerosis 108 103-110.
14. Basu S (1998) Radioimmunoassay of 8-iso-prostaglandin F2alpha: An index for oxidative injury via free radical catalysed lipid peroxidation. Prostaglandins Leukot Essent Fatty Acids 58, 319-325.
15. Basu S (1998) Radioimmunoassay of 15-keto-13,14-dihydroprostaglandin F2alpha: An index for inflammation via cyclooxygenase catalysed lipid peroxidation. Prostaglandins Leukot Essent Fatty Acids 58, 347-352.
16. Esposito K, Ciotola M, Schisano B, et al. (2006) Oxidative stress in the metabolic syndrome. J Endocrinol Invest 29, 791-795.
17. Altomare E, Vendemiale G, Chicco D, et al. (1992) Increased lipid peroxidation in type 2 poorly controlled diabetic patients. Diabete Metab 18, 264-271.
18. Basu S (2004) Isoprostanes: Novel bioactive products of lipid peroxidation. Free Radic Res 38, 105-122.
19. Ceriello A, Mercuri F, Quagliaro L, et al. (2001) Detection of nitrotyrosine in the diabetic plasma: Evidence of oxidative stress. Diabetologia 44, 834-838.
20. Hinokio Y, Suzuki S, Hirai M, et al. (1999) Oxidative DNA damage in diabetes mellitus: Its association with diabetic complications. Diabetologia 42, 995-998.
21. Dincer Y, Akcay T, Alademir Z, et al. (2002) Assessment of DNA base oxidation and glutathione level in patients with type 2 diabetes. Mutat Res 505, 75-81.
22. Abramsson-Zetterberg L, Zetterberg G, et al. (2000) Human cytogenetic biomonitoring using flow-cytometric analysis of micronuclei in transferrin-positive immature peripheral blood reticulocytes. Environ Mol Mutagen 36, 22-31.
23. Pickup JC, Chusney GD, Thomas SM, et al. (2000) Plasma interleukin-6, tumour necrosis factor alpha and blood cytokine production in type 2 diabetes. Life Sci 67, 291-300.
24. Ford ES (1999) Body mass index, diabetes, and C-reactive protein among U.S. adults. Diabetes Care 22, 1971-1977.